Versioned tabular datasets with provenance tracking and citation indexing
No description
No description
Registry of AD drug targets, approved and failed, with mechanism, status, and evidence quality.
Curated cell-type marker genes for microglia, astrocytes, neurons, and oligodendrocytes in AD research.
Registry of CSF, plasma, and imaging biomarkers used for AD diagnosis, staging, and monitoring. Initial v1 set covers the established A/T/N framework biomarkers (amyloid, tau, neurodegeneration) plus
Curated registry of Phase 3 AD clinical trials with their outcomes, mechanism, and (for failures) the most likely contributing factors. Initial v1 set focuses on landmark anti-amyloid and secretase tr
Curated registry of genetic loci associated with Alzheimer's disease risk, including landmark common variants identified by GWAS and the autosomal-dominant familial AD genes (APP, PSEN1, PSEN2). Effec